Jpmorgan Chase & CO Vor Biopharma Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,038 shares of VOR stock, worth $10,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,038
Previous 983
1124.62%
Holding current value
$10,473
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VOR
# of Institutions
57Shares Held
41.2MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA22.7MShares$19.8 Million0.22% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$5.53 Million1.77% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT2.47MShares$2.15 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.7 Million0.0% of portfolio
-
Cowen And Company, LLC1.22MShares$1.06 Million0.02% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $33.1M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...